• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

Aptivus (tipranavir) Capsules and Oral Solution

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – April 2011

Summary View


7.2 Drug Interactions

  • table 4: ...raltegravir added...
  • "see related changes in Clinical pharmacology table 7 and 8"